{"id":"https://openalex.org/W73437337","doi":null,"title":"Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.","display_name":"Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.","alternate_titles":[],"publication_year":1994,"publication_date":"1994-11-01","ids":{"openalex":"https://openalex.org/W73437337","mag":"73437337","pmid":"https://pubmed.ncbi.nlm.nih.gov/7874668"},"language":"en","primary_location":{"id":"pmid:7874668","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7874668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian journal of psychiatry. Revue canadienne de psychiatrie","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W73437337"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109006830","display_name":"Henderson Andrew","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160690","display_name":"Government of Manitoba","ror":"https://ror.org/05tvcyg29","country_code":"CA","type":"government","lineage":["https://openalex.org/I4210160690"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"H G Andrew","raw_affiliation_strings":["Community and Mental Health Services Division, Ministry of Health, Province of Manitoba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community and Mental Health Services Division, Ministry of Health, Province of Manitoba","institution_ids":["https://openalex.org/I4210160690"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109006830"],"corresponding_institution_ids":["https://openalex.org/I4210160690"],"apc_list":null,"apc_paid":null,"fwci":1.0425,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.74142898,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"39","issue":"9 Suppl 2","first_page":"S76","last_page":"S80"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9430000185966492},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":1.0},{"id":"https://openalex.org/keywords/dystonia","display_name":"dystonia","score":0.8199999928474426},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":1.0},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neuroleptic-induced-movement-disorders","display_name":"neuroleptic-induced movement disorders","score":0.75},{"id":"https://openalex.org/keywords/dopamine-receptor-supersensitivity","display_name":"dopamine receptor supersensitivity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9710000157356262},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9449999928474426},{"id":"https://openalex.org/keywords/risk-prediction","display_name":"risk prediction","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.8660454750061035},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.8164448142051697},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.751934289932251},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.684562087059021},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.6554051637649536},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6270896196365356},{"id":"https://openalex.org/C2778559928","wikidata":"https://www.wikidata.org/wiki/Q906492","display_name":"Dystonia","level":2,"score":0.6035507917404175},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.5528143644332886},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5459524393081665},{"id":"https://openalex.org/C2778261627","wikidata":"https://www.wikidata.org/wiki/Q2608695","display_name":"Movement disorders","level":3,"score":0.44074922800064087},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43379032611846924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34149736166000366},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.33741459250450134},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2579525411128998},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25335684418678284},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.25049394369125366},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13186031579971313},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.10862576961517334}],"mesh":[{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009460","descriptor_name":"Neurologic Examination","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7874668","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7874668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian journal of psychiatry. Revue canadienne de psychiatrie","raw_type":"Journal Article"},{"id":"mag:73437337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7874668","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023455708","https://openalex.org/W1968802391","https://openalex.org/W2144086396","https://openalex.org/W2212027594","https://openalex.org/W2404523820","https://openalex.org/W1997784657","https://openalex.org/W2275813378","https://openalex.org/W4254300694","https://openalex.org/W193846426","https://openalex.org/W87425311"],"abstract_inverted_index":{"The":[0,45],"author":[1],"reviews":[2],"the":[3,26,56,73,81,91],"relationship":[4],"between":[5],"extrapyramidal":[6],"syndromes":[7],"(EPS)":[8],"such":[9],"as":[10],"dystonia,":[11],"akathisia":[12],"and":[13,15],"parkinsonism,":[14],"tardive":[16],"dyskinesia":[17],"(TD),":[18],"characterized":[19],"clinically":[20],"by":[21],"late-onset":[22],"repetitive":[23],"movements.":[24],"While":[25],"pathophysiological":[27],"mechanisms":[28],"are":[29],"unclear,":[30],"neuroleptic-induced":[31],"EPS":[32,69,103],"have":[33],"been":[34,52,62],"shown":[35,53],"to":[36,54,72],"be":[37,88],"associated":[38],"with":[39,100],"a":[40,101,108],"higher":[41],"risk":[42],"of":[43,47,58,75,111],"TD.":[44,59,112],"appearance":[46],"EPS,":[48],"however,":[49],"has":[50,61],"not":[51],"predict":[55],"occurrence":[57],"It":[60],"hypothesized":[63],"that":[64],"dopamine":[65,76],"hypofunction":[66],"resulting":[67],"in":[68,90,107],"may":[70,105],"lead":[71],"development":[74],"receptor":[77],"supersensitivity,":[78],"thereby":[79],"increasing":[80],"TD":[82],"risk.":[83],"If":[84],"this":[85],"theory":[86],"can":[87],"validated":[89],"clinical":[92],"setting,":[93],"atypical":[94],"neuroleptics":[95],"(for":[96],"example,":[97],"clozapine,":[98],"risperidone)":[99],"lower":[102,109],"liability":[104],"result":[106],"incidence":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W73437337","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
